Could the addition of hp-hMG and GnRH antagonists modulate the response in IVF-ICSI cycles?

References

• Al-Inany, H. G., Abou-Setta, A. M., Aboulghar, M. (2006). Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database of Systematic Reviews, 19, CD001750.
   Google Scholar
• Andersen, A. N., Devroey, P., Arce, J. C. (2006). Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Human Reproduction, 21, 3217–3227.
   PubMed Web of Science ®Google Scholar
• Andersen, A. N., Goossens, V., Ferraretti, A. P., Bhattacharya, S., Felberbaum, R., de Mouzon, J., Nygren, K. G.; European IVF-monitoring (EIM) Consortium; & European Society of Human Reproduction and Embryology (ESHRE). (2008). Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Human Reproduction, 23, 756–771.
   PubMed Web of Science ®Google Scholar
• Arce, J. C., Nyboe Andersen, A., Collins, J. (2005). Resolving methodological and clinical issues in the design of efficacy trials in assisted reproductive technologies: a mini-review. Human Reproduction, 20, 1757–1771.
   Google Scholar
• Bosch, E., Vidal, C., Labarta, E., Simon, C., Remohi, J., Pellicer, A. (2008). Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists – a randomized study. Human Reproduction, 23, 2346–2351.
   PubMed Web of Science ®Google Scholar
• Dell'aquila, M. E., Ambruosi, B., De Santis, T., Cho, Y. S. (2009). Mitochondrial distribution and activity in human mature oocytes: gonadotropin-releasing hormone agonist versus antagonist for pituitary down-regulation. Fertility and Sterility, 91, 249–255.
   Google Scholar
• Erickson, G. F., Wang, C., Hsueh, A. J. (1979). FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature, May 24, 279(5711), 336–338.
   Google Scholar
• Fanchin, R., Righini, C., Olivennes, F., Taieb, J., de Ziegler, D., Frydman, R. (1999). Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation. Fertility and Sterility, 71, 174–181.
   PubMed Web of Science ®Google Scholar
• Fanchin, R., Righini, C., Ayoubi, J. M., Olivennes, F., de Ziegler, D., Frydman, R. (2000). New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer. Fertility and Sterility, 74, 274–281.
   PubMedGoogle Scholar
• Gómez-Palomares, J. L., Acevedo-Martín, B., Chávez, M., Manzanares, M. A., Ricciarelli, E., Hernández, E. R. (2008). Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles. Fertility and Sterility, 89, 620–624.
   PubMed Web of Science ®Google Scholar
• Gribbons, B., Herman, J. (1997). True and quasi-experimental designs. Practical Assessment, Research and Evaluation, 5, 14.
   Google Scholar
• Griesinger, G., Diedrich, K., Tarlatzis, B. C., Kolibianakis, E. M. (2006). GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reproductive Biomedicine Online, 13, 628–638.
   PubMed Web of Science ®Google Scholar
• Golan, A., Ron-el, R., Herman, A., Soffer, Y., Weinraub, Z., Caspi, E. (1989). Ovarian hyperstimulation syndrome: an update review. Obstetrical and Gynecological Survey, 44, 430–440.
   PubMedGoogle Scholar
• Grøndahl, M. L., Borup, R., Lee, Y. B. Myrhøj, V., Meinertz, H., Sørensen, S. (2009). Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin. Fertility and Sterility, 91, 1820–1830.
   PubMed Web of Science ®Google Scholar
• Hillier, S. G., Zeleznik, A. J., Ross, G. T. (1978). Independence of steroidogenic capacity and luteinizing hormone receptor induction in developing granulosa cells. Endocrinology, 102, 937–946.
   PubMed Web of Science ®Google Scholar
• Huirne, J. A., Homburg, R., Lambalk, C. B. (2007). Are GnRH antagonists comparable to agonists for use in IVF? Human Reproduction, 22, 2805–2813.
   PubMed Web of Science ®Google Scholar
• Kilani, Z., Dakkak, A., Ghunaim, S., Cognigni, G. E., Tabarelli, C., Parmegiani, L., et al (2003). A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes. Human Reproduction, 18, 1194–1199.
   PubMed Web of Science ®Google Scholar
• Koichi, K., Yukiko, N., Shima, K., Sachiko, S. (2006). Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol. Journal of Assisted Reproduction and Genetics, 23, 223–228.
   Google Scholar
• Kolibianakis, E. M., Collins, J., Tarlatzis, B. C., Devroey, P., Diedrich, K., Griesinger, G. (2006). Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Human Reproduction Update, 12, 651–671.
   PubMed Web of Science ®Google Scholar
• Mochtar, M. H., Van der Veen, F., Ziech, M., van Wely, M. (2007). Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews, 18, CD005070.
   Google Scholar
• Olivennes, F., Cunha-Filho, J. S., Fanchin, R., Bouchard, P., Frydman, R. (2002). The use of GnRH antagonists in ovarian stimulation. Human Reproduction Update, 8, 279–290.
   PubMed Web of Science ®Google Scholar
• Platteau, P., Andersen, A. N., Balen, A., Devroey, P., Sørensen, P., Helmgaard, L., Arce, J. C. (2006). Menopur ovulation induction (MOI) study group. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Human Reproduction, 21, 1798–1804.
   PubMed Web of Science ®Google Scholar
• Segaloff, D. L., Wang, H. Y., Richards, J. S. (1990). Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization. Molecular Endocrinology, 4, 1856–1865.
   PubMedGoogle Scholar
• Serafini, P., Yadid, I., Motta, E. L., Alegretti, J. R., Fioravanti, J., Coslovsky, M. (2006). Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Fertility and Sterility, 86, 830–838.
   PubMed Web of Science ®Google Scholar
• Smitz, J., Andersen, A. N., Devroey, P., Arce, J. C. (2007). Endocrine profile in serum and follicular fluid differs after ovarian stimulation with hp-hMG or recombinant FSH in IVF patients. Human Reproduction, 22, 676–687.
   PubMed Web of Science ®Google Scholar
• Van Wely, M., Westergaard, L. G., Bossuyt, P. M., Van der Veen, F. (2003). Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews, 1, CD003973.
   Google Scholar
• Veeck, L. (1992). Evolución de ovocitos y preembriones en el laboratorio FIV. In Remohi, J., Pellicer, A., Bonilla Musoles, F., (Eds), Avances en Reproducción Asistida. Madrid: Ediciones Diaz de Santos S.A, 117–162.
   Google Scholar
• Weissman, A., Ravhon, A., Biran, G., Levin, D., Golan, A., Levran, D. (2007). Follicular growth and development under continuous gonadotropin-releasing hormone antagonist administration. Fertility and Sterility, 88, 1 677.e15–e17.
   Google Scholar
• Westergaard, L. G., Erb, K., Laursen, S. B., Rex, S., Rasmussen, P. E. (2001). Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertility and Sterility, 76, 543–549.
   PubMed Web of Science ®Google Scholar
• Zeleznik, A. J., Hillier, S. G. (1984). The role of gonadotropins in the selection of the preovulatory follicle. Clinical Obstetrics and Gynecology, 27, 927–940.
   PubMed Web of Science ®Google Scholar
• Zeleznik, A. J., Midgley, A. R. Jr., Reichert, L. E. Jr. (1974). Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology, 95, 818–825.
   PubMed Web of Science ®Google Scholar
• Ziebe, S., Lundin, K., Janssens, R., Helmgaard, L., Arce, J. C.; MERIT (Menotrophin vs. Recombinant FSH in vitro Fertilisation Trial) Group. (2007). Influence of ovarian stimulation with hp-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Human Reproduction, 22, 2404–2413.
   PubMed Web of Science ®Google Scholar